Page 7 - Peter Greenleaf News Today

Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan Aurinia to receive $50 million U.S. upfront payment in addition to up to $50 million U.S. in regulatory and reimbursement milestone payments – – Agreement includes royalties of up to 20 percent on net sales payable to Aurinia – Aurinia Pharmaceuticals Inc. today announced it has entered into a collaboration and license ag...

DGAP-News: Immun ... DGAP-News: Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US vom 17.12.2020, 09:00 Uhr Bild: pixabay.com DGAP-News: Immune Regulation Limited / Key word(s): Personnel Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US 17.12.2020 / 09:00 The issuer is solely respon...

Immune Regulation Limited Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US DGAP-News: Immune Regulation Limited / Key word(s): Personnel Immune Regulation Limited: Immune Regulation appoints New Chairman and builds out Senior Management Team with standout industry professionals in the US 17.12.2020 / 09:00 The issuer is solely responsible for the content of this announcement. Immune Regulation appoints New Chairman and...

Search jobs 17-Dec-2020 Immune Regulation Appoints New Chairman and Builds Out Senior Management Team with Standout Industry Professionals in the US LONDON, UK and NEW ORLEANS, US, December 17, 2020 / B3C newswire / --Immune Regulation Ltd, a US and UK based clinical stage biotechnology company announced today a series of appointments to build out the Board and leadership team that will work alongside Jonathan Rigby, Group CEO of Immune Regulation, i...